More harm than good
- 1 January 2014
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The Journal of Trauma and Acute Care Surgery
- Vol. 76 (1), 54-61
- https://doi.org/10.1097/ta.0b013e3182aafd15
Abstract
BACKGROUND The purposes of this study were to examine the current Brain Trauma Foundation recommendation for antiseizure prophylaxis with phenytoin during the first 7 days after traumatic brain injury (TBI) in preventing seizures and to determine if this medication affects functional recovery at discharge. METHODS The records of adult (age ≥ 18 years) patients with blunt severe TBI who remained in the hospital at least 7 days after injury were retrospectively reviewed from January 2008 to January 2010. Clinical seizure rates during the first 7 days after injury and functional outcome at discharge were compared for the two groups based on antiseizure prophylaxis, no prophylaxis (NP) versus phenytoin prophylaxis (PP). Statistical analysis was performed using χ2. RESULTS A total of 93 adult patients who met the previously mentioned criteria were identified (43 [46%] NP group vs. 50 [54%] PP group). The two groups were well matched. Contrary to expectation, more seizures occurred in the PP group as compared with the NP group; however, this did not reach significance (PP vs. NP, 2 [4%] vs. 1 [2.3%], p = 1). There was no significant difference in the two groups (PP vs. NP) as far as disposition are concerned, mortality caused by head injury (4 [8%] vs. 3 [7%], p = 1), discharge home (16 [32%] vs. 17 [40%], p = 0.7), and discharge to rehabilitation (30 [60%] vs. 23 [53%], p = 0.9). However, with PP, there was a significantly longer hospital stay (PP vs. NP, 36 vs. 25 days, p = 0.04) and significantly worse functional outcome at discharge based on Glasgow Outcome Scale (GOS) score (PP vs. NP, 2.9 vs. 3.4, p < 0.01) and modified Rankin Scale score (2.3 ± 1.7 vs. 3.1 ± 1.5, p = 0.02). CONCLUSION PP may not decrease early posttraumatic seizure and may suppress functional outcome after blunt TBI. These results need to be verified with randomized studies before recommending changes in clinical practice and do not apply to penetrating trauma. LEVEL OF EVIDENCE Therapeutic study, level IV; epidemiologic study, level III.Keywords
This publication has 20 references indexed in Scilit:
- A Critical Look at Phenytoin Use for Early Post-Traumatic Seizure ProphylaxisCanadian Journal of Neurological Sciences, 2011
- Anticonvulsant Use and Outcomes After Intracerebral HemorrhageStroke, 2009
- Prophylactic Antiepileptic Drug Use is Associated with Poor Outcome Following ICHNeurocritical Care, 2009
- Survey of Management of Severe Head Injury in CanadaCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2007
- Phenytoin Exposure Is Associated With Functional and Cognitive Disability After Subarachnoid HemorrhageStroke, 2005
- Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxisJournal of Neurosurgery, 1999
- A Randomized, Double-Blind Study of Phenytoin for the Prevention of Post-Traumatic SeizuresThe New England Journal of Medicine, 1990
- Phenytoin: Basic and clinical pharmacologyMedicinal Research Reviews, 1983
- Failure of prophylactically administered phenytoin to prevent late posttraumatic seizuresJournal of Neurosurgery, 1983
- Phenytoin hypersensitivityNeurology, 1979